In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Acadia Healthcare Company Inc (NASDAQ: ACHC) closed the day trading at $21.59 up 2.18% from the previous closing price of $21.13. In other words, the price has increased by $2.18 from its previous closing price. On the day, 2.2 million shares were traded. ACHC stock price reached its highest trading level at $22.045 during the session, while it also had its lowest trading level at $21.22.
Ratios:
For a better understanding of ACHC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On February 28, 2025, Barclays Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $43 to $35.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on January 07, 2025, while the target price for the stock was maintained at $70.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’24 when Hollinsworth John S. bought 20,000 shares for $53.02 per share.
Hollinsworth John S. bought 10,000 shares of ACHC for $812,065 on Aug 29 ’24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 1993763072 and an Enterprise Value of 4417048064. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.23, and their Forward P/E ratio for the next fiscal year is 7.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.62 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at 1.368 whereas that against EBITDA is 6.852.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.89, which has changed by -0.71862376 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $82.40, while it has fallen to a 52-week low of $17.12. The 50-Day Moving Average of the stock is -1.45%, while the 200-Day Moving Average is calculated to be -31.02%.
Shares Statistics:
Over the past 3-months, ACHC traded about 2.04M shares per day on average, while over the past 10 days, ACHC traded about 3145220 shares per day. A total of 92.35M shares are outstanding, with a floating share count of 90.71M. Insiders hold about 1.77% of the company’s shares, while institutions hold 115.67% stake in the company. Shares short for ACHC as of 1753920000 were 10540093 with a Short Ratio of 5.17, compared to 1751241600 on 11052418. Therefore, it implies a Short% of Shares Outstanding of 10540093 and a Short% of Float of 13.600000000000001.
Earnings Estimates
Its stock is currently analyzed by 13.0 different market analysts. The consensus estimate for the next quarter is $0.62, with high estimates of $0.79 and low estimates of $0.53.
Analysts are recommending an EPS of between $2.58 and $2.4 for the fiscal current year, implying an average EPS of $2.51. EPS for the following year is $2.76, with 14.0 analysts recommending between $3.13 and $2.35.
Revenue Estimates
13 analysts predict $853.3M in revenue for the current quarter. It ranges from a high estimate of $878.2M to a low estimate of $816.76M. As of the current estimate, Acadia Healthcare Company Inc’s year-ago sales were $815.63MFor the next quarter, 13 analysts are estimating revenue of $835.71M. There is a high estimate of $865.67M for the next quarter, whereas the lowest estimate is $821M.
A total of 13 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.35B, while the lowest revenue estimate was $3.3B, resulting in an average revenue estimate of $3.32B. In the same quarter a year ago, actual revenue was $3.15BBased on 13 analysts’ estimates, the company’s revenue will be $3.57B in the next fiscal year. The high estimate is $3.64B and the low estimate is $3.48B.
